A restrictive stoma policy after colorectal anastomosis in ovarian cancer based on ghost ileostomy use.

Data de publicació: 11/04/2024 Data Ahead of Print: 11/04/2024

Autors de IIS La Fe

Autors aliens a IIS La Fe

Albert MM
Cruz MA
Guijarro Campillo RA

Grups d'Investigació

Cirugía digestiva y Cuidados perioperatorios

Leader

Matteo Frasson
Medicina Reproductiva

Investigador Principal

José Morales Roselló

Abstract

BACKGROUND: The incidence of anastomotic leak after colorectal anastomosis in ovarian cancer has been reported to be much lower than that in colorectal cancer patients. Regarding the use of protective manoeuvres (diverting ileostomy) as suggested by clinical guidelines, the goal should be the implementation of a restrictive stoma policy for ovarian cancer patients, given the low rate of anastomotic leakage in this population. MATERIAL AND METHODS: Patients who underwent cytoreduction surgery in a single centre (University Hospital La Fe, Valencia Spain) due to ovarian cancer between January 2010 and June 2023 were classified according to two groups: a non-restrictive stoma policy group (Group A) and a restrictive stoma policy group (Group B). RESULTS: A total of 256 patients were included in the analysis (group A 52 % vs group B 48 %). The use of protective diverting ileostomy was lower in the restrictive stoma policy group (14 % vs 6.6 %), and the use of ghost ileostomy was 32 % vs 87 % in groups A and B, respectively (p < 0.00001). No differences were found in the anastomotic leak rate, which was 5.2 % in the non-restrictive group and 3.2 % in the restrictive stoma policy group (p = 0.54). CONCLUSION: The use of a restrictive stoma policy based on the use of ghost ileostomy reduces the rate of diverting ileostomy in patients with ovarian cancer after colorectal resection and anastomosis. Furthermore, this policy is not associated with an increased rate of anastomotic leakage nor with an increased rate of morbi-mortality related to the leak.

Dades de la publicació

ISSN/ISSNe:: 0748-7983, 1532-2157
Tipus:: Article
Pàgines:: 108325-108325
DOI:: 10.1016/j.ejso.2024.108325
PubMed:: 38636248
Factor d'Impacte:: 1,016 SCImago ℠
Quartil:: Q1 SCImago ℠

Documents

No hi ha documents

Mètriques

Filiacions

Lago V:: Gynecologic Oncology Unit, University Hospital La Fe, Valencia, Spain

CEU Cardenal Herrera University, Valencia, Spain
Albert MM:: Gynecologic Oncology Unit, University Hospital La Fe, Valencia, Spain
Cruz MA:: Gynecologic Oncology Unit, University Hospital La Fe, Valencia, Spain
Guijarro Campillo RA:: University Hospital La Arrixaca, Murcia, Spain
Padilla-Iserte P:: Gynecologic Oncology Unit, University Hospital La Fe, Valencia, Spain
Matute L:: Gynecologic Oncology Unit, University Hospital La Fe, Valencia, Spain
Gurrea M:: Gynecologic Oncology Unit, University Hospital La Fe, Valencia, Spain
Flor B:: Colorectal Surgery Unit, University Hospital La Fe, Valencia, Spain
Domingo S:: Gynecologic Oncology Unit, University Hospital La Fe, Valencia, Spain